All Products
Also known as
Orgasm-associated urinary incontinence, orgasm-induced urinary incontinence, climax-associated incontinence, ejaculatory incontinence, coital incontinence (male)
Definition
Climacturia is defined as the involuntary loss of urine during orgasm (sexual climax)1. This condition commonly occurs as a side effect of radical prostatectomy (RP) for prostate cancer treatment2. The pathophysiology is primarily attributed to damage to the internal urethral sphincter during surgery, which normally prevents urine from leaking during sexual activity3. When the external sphincter relaxes during orgasm, the compromised internal sphincter cannot maintain continence, resulting in urine leakage4. Studies have also found correlations between climacturia and reduced functional urethral length5, suggesting anatomical changes contribute to this condition. The severity varies from a few drops to more than an ounce (30 mL) of urine leakage during orgasm1.
Clinical Context
Climacturia occurs primarily in men who have undergone radical prostatectomy for prostate cancer treatment1. Studies report prevalence rates ranging from 20% to 93%, with an average of approximately 30% of patients experiencing this condition post-surgery2. The condition can significantly impact quality of life and sexual satisfaction, with approximately 45% of affected men reporting psychological distress3. Many patients avoid sexual activity due to embarrassment, potentially straining intimate relationships4.
Management options range from conservative to surgical interventions. Conservative approaches include emptying the bladder before sexual activity and pelvic floor muscle training (PFMT)5. Device-based solutions include penile variable tension loops and soft silicone occlusion loops, which compress the urethra to prevent leakage during orgasm2. For more severe cases, surgical interventions may be considered, including artificial urethral sphincters (AUS), male urethral slings, and the Mini-Jupette graft2. The latter is particularly valuable for patients experiencing both erectile dysfunction and climacturia2. Treatment selection should be individualized based on severity, patient preference, and concurrent conditions2.